A Phase 4, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Persistent Asthma
Latest Information Update: 25 Apr 2024
At a glance
- Drugs Dupilumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms MORPHEO
- Sponsors Sanofi
- 25 Jan 2024 Status changed from active, no longer recruiting to completed.
- 23 Aug 2023 Planned End Date changed from 15 Sep 2023 to 26 Dec 2023.
- 23 Aug 2023 Planned primary completion date changed from 1 May 2023 to 3 Oct 2023.